Prof Stevens obtained her PhD at the University of Nottingham, did her postdoctoral research at the Massachusetts Institute of Technology, and led a highly interdisciplinary research programme at Imperial College London from 2004-2023 where she still holds a part-time position. Since 2015, she has also been part-time Professor of Biomaterials and Regenerative Medicine in the Department of Medical Biochemistry and Biophysics at the Karolinska Institutet, Sweden. Professor Dame Stevens is an international leader in ground-breaking biosensing technologies, transformative regenerative medicine and advanced therapeutics approaches The Stevens Group’s biomaterial innovations are also applied to soft robotics, and to the interface between living and non-living matter, and are underpinned by collaborations with molecular dynamics experts and data scientists in the digital health field. This work is inherently interdisciplinary, so the Stevens Group is made up of a diverse cast of materials scientists, engineers, chemists, biologists, physicists and surgeons.

Professor Dame Stevens has published extensively in leading journals such as Science, Nature, Nature Nanotechnology and Nature Materials; and has won >40 awards. She is a serial entrepreneur and has significant expertise and experience in commercialization of devices, with numerous patents filed and 4 spin-out companies based on her research.